03/03/2025
7:42 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:27 PM | ARMISTICE CAPITAL, LLC (Filed by)
BioXcel Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/06/2025
7:44 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
4:28 PM | BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
3:15 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/20/2025
11:15 PM | BioXcel Therapeutics (Filer)
| Form EFFECT | |
01/16/2025
7:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2025
7:03 AM | BioXcel Therapeutics (Issuer)
Patni Rajiv (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/16/2025
7:04 AM | BioXcel Therapeutics (Issuer)
Patni Rajiv (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
7:00 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
7:01 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for BTAI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioXcel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/10/2025
7:03 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:45 PM | BioXcel Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/08/2025
6:45 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2024
3:15 PM | BioXcel Therapeutics (Filer)
| Form DEF 14A | |
12/18/2024
7:19 PM | BioXcel Therapeutics (Subject)
Oaktree Capital Group Holdings GP, LLC (Filed by)
| Form SCHEDULE 13G | |
12/18/2024
4:16 PM | BioXcel Therapeutics (Filer)
| Form PRE 14A | |
12/18/2024
4:20 PM | BioXcel Therapeutics (Subject)
Qatar Investment Authority (Filed by)
| Form SCHEDULE 13G | |
12/17/2024
5:10 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
5:03 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
5:04 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
5:06 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
5:08 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:21 PM | BioXcel Therapeutics (Subject)
O'Neill Vincent (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
2:33 PM | BioXcel Therapeutics (Subject)
Steinhart Richard I (Reporting)
| Form 144/A | |
12/16/2024
2:23 PM | BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
2:00 PM | BioXcel Therapeutics (Subject)
Steinhart Richard I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
1:10 PM | BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024
3:05 PM | BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/25/2024
3:06 PM | BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
5:00 AM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
11/21/2024
3:43 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2024
3:46 PM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
11/14/2024
8:10 AM | BioXcel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
3:08 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
8:53 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
8:54 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
8:54 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
8:55 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
8:55 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
“Amazon Coin” set to outperform Bitcoin (Ad) Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017…
And has spotted 44 different coins that have returned over 100%...
But today, Chris is now making the biggest crypto call of his ENTIRE career… #1 FREE Crypto for 2025 |
10/03/2024
3:33 PM | BioXcel Therapeutics (Subject)
Wiley Matthew T. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
3:40 PM | BioXcel Therapeutics (Subject)
Rodriguez Javier (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
3:17 PM | BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2024
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
6:17 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4/A | |
09/17/2024
6:18 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
6:19 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
6:20 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
6:21 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
6:21 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
6:23 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
4:42 PM | BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:26 PM | BioXcel Therapeutics (Subject)
Wiley Matthew T. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:16 PM | BioXcel Therapeutics (Subject)
Rodriguez Javier (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
2:48 PM | BioXcel Therapeutics (Subject)
O'Neill Vincent (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
1:58 PM | BioXcel Therapeutics (Subject)
Steinhart Richard I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
12:23 PM | BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
9:47 AM | BioXcel Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
09/09/2024
3:15 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
6:16 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:05 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2024
3:41 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2024
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
6:05 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
8:22 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4/A | |
06/18/2024
8:24 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:25 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:25 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:26 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:26 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:27 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
2:13 PM | BioXcel Therapeutics (Subject)
Rodriguez Javier (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
1:34 PM | BioXcel Therapeutics (Subject)
Wiley Matthew T. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
1:09 PM | BioXcel Therapeutics (Subject)
O'Neill Vincent (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
12:46 PM | BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
12:04 PM | BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
12:21 PM | BioXcel Therapeutics (Subject)
Steinhart Richard I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
6:00 PM | BioXcel Therapeutics (Issuer)
Bray June (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:00 PM | BioXcel Therapeutics (Issuer)
MILLER MICHAEL PATRICK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:01 PM | BioXcel Therapeutics (Issuer)
MUELLER PETER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:01 PM | BioXcel Therapeutics (Issuer)
Laumas Sandeep (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:02 PM | BioXcel Therapeutics (Issuer)
Votruba Michal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
7:29 PM | BioXcel LLC (Filed by)
BioXcel Therapeutics (Subject)
| Form SC 13D/A | |
06/06/2024
7:35 PM | BioXcel Holdings, Inc. (Reporting)
BioXcel LLC (Reporting)
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
6:30 AM | BioXcel Therapeutics (Filer)
| Form 424B7 | |
05/09/2024
8:05 AM | BioXcel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
6:12 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
5:01 AM | BioXcel Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024
5:03 AM | BioXcel Therapeutics (Filer)
| Form DEFA14A | |
04/22/2024
6:10 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
“Amazon Coin” set to outperform Bitcoin (Ad) Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017…
And has spotted 44 different coins that have returned over 100%...
But today, Chris is now making the biggest crypto call of his ENTIRE career… #1 FREE Crypto for 2025 |
04/19/2024
6:01 AM | BioXcel Therapeutics (Filer)
| Form PRE 14A | |
04/10/2024
6:05 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
6:30 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
6:31 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
6:32 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
6:32 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
6:32 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
6:30 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
1:50 PM | BioXcel Therapeutics (Subject)
Wiley Matthew T. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free BTAI Stock Alerts